Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$0.00
Net Income/Share
$-1.71-57.9%
Operating CF/Share
$-1.44-61.8%
Free CF/Share
$-1.44-61.7%
Cash/Share
$2.86-43.1%
Book Value/Share
$3.03-45.0%
Tangible Book/Share
$3.03-44.9%
Equity/Share
$3.03-45.0%
Interest Debt/Share
$0.56-6.1%
Valuation
Market Cap
$103.22M-44.6%
Enterprise Value
P/E Ratio$97.30M-34.2%
-1.01+71.6%
P/S Ratio0.00
P/OCF Ratio
-1.20+72.3%
P/FCF Ratio
P/B Ratio-1.20+72.3%
0.57-18.6%
P/TB Ratio
EV/Sales0.57-18.6%
0.00
EV/EBITDA
-0.99+65.4%
Profitability
Earnings Yield-99.13%-252.5%
FCF Yield-83.54%-261.0%
ROE-56.28%-186.9%
ROIC-53.90%-162.8%
Return on Tangible Assets-42.82%-153.4%
Capital Allocation
CapEx/OCF
-0.02%+61.9%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.09-21.2%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity0.16+53.1%
Debt/Assets0.12+35.3%
Net Debt/EBITDA
Current Ratio0.06-91.9%
6.46-66.0%
Interest Coverage-28.03x+73.4%
Income Quality0.84+2.5%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.91-53.9%